Literature DB >> 23701079

Gadofosveset trisodium: abdominal and peripheral vascular applications.

Amy Srur Sabach1, Mary Bruno, Danny Kim, Thomas Mulholland, Lawrence Lee, Samantha Kaura, Ruth P Lim.   

Abstract

OBJECTIVE: The purpose of this review is to illustrate various applications of gadofosveset trisodium in evaluating abdominal and peripheral vascular disease. The basic properties, technical considerations, and clinical and potential future applications of gadofosveset are described.
CONCLUSION: Gadofosveset trisodium facilitates comprehensive high-resolution arterial and venous MR angiography. Because of its prolonged intravascular residence time, gadofosveset trisodium is particularly useful for evaluating venous, dynamic, and functional vascular disease with a single low-dose contrast injection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23701079     DOI: 10.2214/AJR.12.8991

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.

Authors:  Shruti Kanakia; Jimmy Toussaint; Praveen Kukarni; Stephen Lee; Sayan Mullick Chowdhury; Slah Khan; Sandeep K Mallipattu; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Graphene Technol       Date:  2016-08-03

2.  3D inversion recovery gradient echo respiratory navigator imaging using Gadofosveset Trisodium in a Fontan Y-graft patient.

Authors:  Sassan Hashemi; W James Parks; Timothy C Slesnick
Journal:  Int J Cardiovasc Imaging       Date:  2014-05-18       Impact factor: 2.357

Review 3.  Extracardiac applications of MR blood pool contrast agent in children.

Authors:  Shannon G Farmakis; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2014-11-19

Review 4.  Advances in axial imaging of peripheral vascular disease.

Authors:  Nandini M Meyersohn; T Gregory Walker; George R Oliveira
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 5.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

6.  Blood Pool Contrast-enhanced Magnetic Resonance Angiography with Correlation to Digital Subtraction Angiography: A Pictorial Review.

Authors:  Martha-Grace Knuttinen; Jillian Karow; Winnie Mar; Margaret Golden; Karen L Xie
Journal:  J Clin Imaging Sci       Date:  2014-11-29

7.  Improved high-resolution pediatric vascular cardiovascular magnetic resonance with gadofosveset-enhanced 3D respiratory navigated, inversion recovery prepared gradient echo readout imaging compared to 3D balanced steady-state free precession readout imaging.

Authors:  Animesh Tandon; Sassan Hashemi; W James Parks; Michael S Kelleman; Denver Sallee; Timothy C Slesnick
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-02       Impact factor: 5.364

8.  MRI with gadofosveset: A potential marker for permeability in myocardial infarction.

Authors:  Begoña Lavin; Andrea Protti; Silvia Lorrio; Xuebin Dong; Alkystis Phinikaridou; René M Botnar; Ajay Shah
Journal:  Atherosclerosis       Date:  2018-04-25       Impact factor: 5.162

9.  High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.

Authors:  Puja Shahrouki; Sarah N Khan; Takegawa Yoshida; Paul J Iskander; Shahnaz Ghahremani; J Paul Finn
Journal:  Pediatr Radiol       Date:  2021-12-22

10.  Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection.

Authors:  Xing Pei Hao; Carissa M Lucero; Baris Turkbey; Marcelino L Bernardo; David R Morcock; Claire Deleage; Charles M Trubey; Jeremy Smedley; Nichole R Klatt; Luis D Giavedoni; Jan Kristoff; Amy Xu; Gregory Q Del Prete; Brandon F Keele; Srinivas S Rao; W Gregory Alvord; Peter L Choyke; Jeffrey D Lifson; Jason M Brenchley; Cristian Apetrei; Ivona Pandrea; Jacob D Estes
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.